EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.64 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,162 | -56.7% | 393,975 | 0.0% | 0.00% | -66.7% |
| Q2 2023 | $277,358 | -26.7% | 393,975 | -6.7% | 0.01% | -25.0% |
| Q1 2023 | $378,625 | -100.0% | 422,102 | +90.1% | 0.01% | -62.5% |
| Q3 2022 | $1,672,000,000 | -12.8% | 222,041 | -27.0% | 0.03% | +14.3% |
| Q2 2022 | $1,917,000,000 | +263.8% | 304,300 | +492.0% | 0.03% | +86.7% |
| Q3 2019 | $527,000,000 | – | 51,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $6,144,000 | 4.00% |
| P.A.W. CAPITAL CORP | 380,000 | $3,363,000 | 2.96% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $6,770,000 | 1.78% |
| Telemetry Investments, L.L.C. | 150,477 | $1,332,000 | 1.51% |
| 683 Capital Management, LLC | 2,683,600 | $23,750,000 | 1.26% |
| KNOTT DAVID M | 276,535 | $2,447,000 | 1.05% |
| Trellus Management Company, LLC | 226,000 | $2,000,000 | 1.04% |
| TOWERVIEW LLC | 140,000 | $1,239,000 | 0.77% |
| Vivo Capital, LLC | 1,791,257 | $15,853,000 | 0.56% |
| CAXTON CORP | 94,083 | $833,000 | 0.54% |